SCHEMBL4299028

SCHEMBL4299028

C=C[C@@H]1C[C@@]1(NC(=O)OC(C)(C)C)C(=O)OCC

nearest known ligand 0.37

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.37
ALDH1A1 P00352 4/20 0.35
KMT2A Q03164 3/20 0.35
MEN1 O00255 2/20 0.35
TSHR P16473 1/20 0.35
MAPK1 P28482 1/20 0.35
CYP1A2 P05177 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
HTT P42858 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
LMNA P02545 1/20 0.31
CPB2 Q96IY4 1/20 0.31
CTSL P07711 1/20 0.31
HCRTR2 O43614 1/20 0.30
CACNA1H O95180 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL329899 1.00 SMN1; SMN2 (0.37) SMN1; SMN2ALDH1A1KMT2AMEN1TSHR
SCHEMBL2052402 1.00 SMN1; SMN2 (0.37) SMN1; SMN2ALDH1A1KMT2AMEN1TSHR
SCHEMBL329900 1.00 SMN1; SMN2 (0.37) SMN1; SMN2ALDH1A1KMT2AMEN1TSHR
SCHEMBL3725588 1.00 SMN1; SMN2 (0.37) SMN1; SMN2ALDH1A1KMT2AMEN1TSHR
SCHEMBL12468506 1.00 SMN1; SMN2 (0.37) SMN1; SMN2ALDH1A1KMT2AMEN1TSHR
SCHEMBL1537604 1.00 SMN1; SMN2 (0.37) SMN1; SMN2ALDH1A1KMT2AMEN1TSHR
SCHEMBL13817962 1.00 SMN1; SMN2 (0.37) SMN1; SMN2ALDH1A1KMT2AMEN1TSHR
SCHEMBL5036319 1.00 SMN1; SMN2 (0.37) SMN1; SMN2ALDH1A1KMT2AMEN1TSHR
Hydrochloric Acid SCHEMBL7644054 0.99 SMN1; SMN2 (0.37) SMN1; SMN2ALDH1A1KMT2AMEN1TSHR
Hydrochloric Acid SCHEMBL1536344 0.99 SMN1; SMN2 (0.37) SMN1; SMN2ALDH1A1KMT2AMEN1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2033654-A1 Macrocyclic isoquinoline peptide inhibitors of hepatitis c virus Bristol-Myers Squibb Company (US) 2009-03-11 EP disclosed